XML 41 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments - Additional Information (Detail) (USD $)
3 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended
Oct. 31, 2013
Oct. 31, 2014
Jul. 31, 2014
Feb. 19, 2014
May 31, 2012
Feb. 21, 2014
Securities Litigation
Feb. 20, 2014
Securities Litigation
Aug. 31, 2013
Securities Litigation
Oct. 31, 2014
Securities Litigation
Jul. 31, 2014
Securities Litigation
Oct. 31, 2013
Securities Litigation
Oct. 31, 2014
Not Designated as Hedging Instrument
Warrant Liability
Feb. 18, 2014
Not Designated as Hedging Instrument
Warrant Liability
Feb. 18, 2014
Not Designated as Hedging Instrument
Warrant Liability
Oct. 31, 2013
Not Designated as Hedging Instrument
Warrant Liability
Oct. 31, 2014
Warrant
Not Designated as Hedging Instrument
Warrant Liability
Jul. 31, 2014
Warrant
Not Designated as Hedging Instrument
Warrant Liability
Feb. 19, 2014
Warrant
Not Designated as Hedging Instrument
Warrant Liability
Feb. 18, 2014
Warrant
Not Designated as Hedging Instrument
Warrant Liability
Jan. 31, 2014
Call Options
Long
Agreement
Oct. 31, 2014
Call Options
Long
Agreement
Oct. 31, 2014
Call Options
Short
Commodity Derivatives
Agreement
Feb. 19, 2014
Oaktree Capital Management, L.P.
May 31, 2012
Oaktree Capital Management, L.P.
Fair Value Measurements [Line Items]                                                
Newly-issued senior notes, face amount                                               $ 225,000,000
Warrants to purchase common stock, issued       4,420,859 4,420,859                                   4,420,859 4,420,859
Exercise price of warrants, value                                             44,200,000  
Warrants exercise inducement fee       15,000,000                                        
Derivative commodities                                       164 28 72    
Derivatives, total notional amount                                       300,000        
Cash equivalents measured at fair value on recurring basis   0                                            
Settlement in cash               11,000,000                                
Settlement agreement, common stock issuable           4,450,000 4,450,000 4,450,000                                
Settlement agreement, common stock issuable fair value             123,300,000   0 0 108,600,000                          
Loss on stock settlement 23,500,000                                              
Derivatives not designated as hedging instruments under ASC 815                             75,100,000 0 0 84,100,000 84,100,000          
Convertible Debt                           75,000,000                    
Expected volatility                       47.50% 45.00%                      
Total outstanding debt 593,153,000 648,405,000 647,415,000                                          
Notes Payable, Fair Value Disclosure   $ 231,600,000